2023 Form 5500 filing — Putnam Drug, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240920111405NAL0007400769001) for Putnam Drug, Inc. 401(K) Plan, reported by Putnam Drug, Inc. Dba Central Drug Of Bessemer Cit under EIN 56-2050341 and plan number 001. It reports 1 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$991Reported net assets
Participants1
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240920111405NAL0007400769001
Plan sponsor
Putnam Drug, Inc. Dba Central Drug Of Bessemer Cit
EIN
56-2050341
Plan number
001
Location
Bessemer City, NC
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$991 total assets
Net assets$991Liabilities$0
Money in vs. money out
Total income / additions$1.8K
Total expenses$48.1K
Benefits paid / distributions$48K
Contributions
Employer$0
Participant$0
Full reported line items
Total assets (EOY)
$991
Total liabilities (EOY)
$0
Net assets (EOY)
$991
Employer contributions
$0
Participant contributions
$0
Total income / additions
$1,819
Benefits paid
$47,978
Administrative expenses
$147
Total expenses
$48,125
Net increase / (decrease)
-$46,306

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240920111405NAL0007400769001 cover?
It is the 2023 Form 5500 filing for Putnam Drug, Inc. 401(K) Plan, reported by Putnam Drug, Inc. Dba Central Drug Of Bessemer Cit (EIN 56-2050341).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages